市場調查報告書
商品編碼
1008065

達生物晶片市場:2020∼2026年

Biochips Market 2020-2026

出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球生物晶片的市場規模,在預測期間(2021∼2027年)以約13.5%的年複合成長率擴大。推動市場成長的主要原因,有技術創新和個人化醫療的需求高漲。再加上醫藥品開發平台增加和對基因學研究導向的產品的新需求,也是加速市場成長的重要要素。但,生物晶片的成本高和嚴格的政府法規等抑制市場成長。由於COVID-19大流行,市場成長更加加速。

本報告提供生物晶片市場相關調查,市場概要,以及各類型,各製造技術,各終端用戶,各地區的趨勢,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢
  • 規則和規則

第3章 競爭情形

  • 企業佔有率分析
  • 主要的策略分析
  • 主要企業分析
    • Danaher Corp.
    • Agilent Technologies, Inc.
    • Illumina,Inc.
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球生物晶片市場,各類型
    • DNA晶片
    • 實驗室晶片
    • 蛋白質晶片
    • 其他
  • 全球生物晶片市場,各製造技術
    • 微陣列
    • 微射流
  • 全球生物晶片市場,各終端用戶
    • 醫院與診斷中心
    • 學術調查機關
    • 生物科技及製藥公司

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories
  • BioFluidix GmbH
  • Cellix Ltd.
  • Dynamic Biosensors GmbH
  • Epigem Ltd.
  • Fluidigm Corp.
  • Horiba, Ltd.
  • LifeSensors Inc.
  • Luminex Corp.
  • Menarini Silicon BiosystemsS.p.a.
  • OriGene Technologies, Inc.
  • Oxford Gene Technology IP Ltd.
  • Randox Laboratories Ltd.
  • Sengenics
  • Thermo Fisher Scientific Inc.
目錄
Product Code: OMR2023358

Global Biochips Market Size, Share & Trends Analysis Report, By Type (DNA Chips, Lab-on-a-Chip, Protein Chips, and Others), By Fabrication Technology (Microarrays and Microfluidics), By End-User (Hospitals and Diagnostic Centers, Academic and Research Institutes, and Biotechnology and Pharmaceutical Companies) and Forecast, 2021-2027

The global biochips market is growing at a CAGR of nearly 13.5% during the forecast period (2021-2027). The major factors that are augmenting the growth of the market include technological innovations and the rising demand for personalized medicine. Furthermore, the rising drug development pipeline and emerging demand for genomics research-oriented product are also some crucial factors accelerating market growth. However, certain factors are restraining the growth of the market, which includes the high cost of biochips and stringent government regulations. Additionally, the COVID-19 pandemic has further accelerated market growth.

Biochips are expected to play a major role in determining the effect of COVID-19 in the body which is further supporting drive the market growth. For instance, in November 2020, Singapore MedTech company, Cell ID Pte. Ltd. developed a test kit that identifies a person with COVID-19. The process is carried on a laptop through an app with the use of a portable genetic test kit that identifies a positive or a negative case within 5 minutes. Quiz PCR Biochips are cost-effective, single-use genetic tests to detect COVID-19, anywhere at any time. In November 2020, the company declared that it could manufacture 8.5 million biochips in a month, which is 17 million tests.

Further, in June 2020, Sengenics, Singapore based Functional Proteomics Company, declared the launch of ImmuSAFE COVID+, a multi-domain, multi-antigen, fully quantitative serology test. ImmuSAFE allows the evaluation of the target epitopes, t Ig class/sub-class (IgG, IgA, IgM; IgG1-4), and titres of antibodies developed across all stages of COVID-19 infection. These stages range from initial exposure, disease development, post-recovery, or post-vaccination. Such results will offer critical insights on whether individuals have high titres of potentially neutralizing antibodies against SARS-CoV-2 that may protect against reinfection or whether booster vaccinations are needed.

Segmental Outlook

The market is segmented based on type, fabrication technology and end-user. By type, the market is segmented into DNA chips, lab on a chip, protein chip and others. Based on the fabrication technology segment, the market is segmented into microarrays and microfluidics. Based on the end-user, the market is segmented into hospitals and diagnostic centers, academic and research institutes and biotechnology and pharmaceutical companies.

Global Biochips Market Share by Type, 2020 (%)

Source: OMR Global

DNA Chips Holds Prominent Share in the Type Segment

DNA microarray tool is used to assess whether the DNA from a specific individual contains a mutation in genes such as BRCA1 and BRCA2. They are mostly used in medical research to speed up the process while minimizing research time. DNA microarrays have applications in clinical diagnostic tests for certain conditions. Often, they are also utilized to determine which drugs are considered as best recommended for individuals, as genes assess how their bodies handle the chemistry corresponding to those drugs.

The innovations in new DNA sequencing technologies have resulted in a shift from microarrays to DNA microarrays. However, microarray tests are regarded as less expensive compared to sequencing and therefore, DNA microarrays may be used for very large studies and some clinical tests. Some of the major companies involved in the development of DNA chips include Thermo Fisher Scientific Inc., Perkin Elmer, Inc., Oxford Gene Technology, Illumina, Inc., Bio-Rad Laboratories Inc and others.

Regional Outlook

The global biochip market is analyzed based on geographical regions, such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Asia-Pacific will likely offer an opportunity for the adoption of biochips owing to the rising molecular diagnostics market and expansion of pharmaceutical companies and rising availability of contract research organizations (CROs) in the region. Moreover, improved healthcare spending and the rising number of multi-specialty hospitals can further contribute to the adoption of biochips in the region.

Global Biochips Market Growth, by Region 2021-2027

Source: OMR Global

North America Holds Prominent Share in the Market

In 2020, North America held the largest share in the market owing to the significant investments in biochips, rising demand for precision medicine, and potential share in drug discovery and development. As per the Personalized Medicine Coalition, in 2019, the US FDA's Center for Drug Evaluation and Research (CDER) approved 48 new molecular entities (NMEs). Of the 44 therapeutic NMEs, 11 of them (25%) are personalized medicines.

Biochips (such as protein biochips, GeneChip, microfluidic biochips, CYP450, nanotechnology-based biochips, and electrochemical biochips) is expected to play a vital role in molecular diagnostics. Additionally, the application of these biochips in point-of-care diagnosis is anticipated to facilitate the development of personalized medicine. The gene expression profiling using microarrays can advance the development of personalized cancer treatment according to the molecular classification of subtypes. With the advent of nanotechnology, refinements in biochip miniaturization will further support molecular diagnostics as well as for the development of personalized medicine.

Market Players Outlook

Key players operating in the market include Bio-Rad Laboratories, Inc., Illumina Inc., Danaher Corp., Agilent Technologies, Inc., and PerkinElmer Inc. To survive in the market, these market players adopt different marketing strategies such as mergers and acquisitions, product launches, and geographical expansion. For Instance, in February 2021, Thermo Fisher Scientific Inc. acquired Mesa Biotech, Inc. to rapidly scale manufacturing volume and drive cost efficiencies. Mesa Biotech develops and commercializes a PCR-based rapid point-of-care (POC) testing platform that is available to detect infectious diseases such as respiratory syncytial virus (RSV), SARS-CoV-2, Strep A, and Influenza A and B.

The patented technology of Mesa Biotech widens the availability of gold-standard nucleic acid PCR amplification to POC diagnostics. The addition of Mesa Biotech rapid, easy-to-use PCR-based test complements the existing offering of Thermo Fisher and will further support to fulfill the continuous demand for COVID-related testing as the company is working to rapidly scale and develop POC tests for other infectious diseases in the future.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global biochips market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules and Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Danaher Corp.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Agilent Technologies, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Illumina,Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Bio-Rad Laboratories, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. PerkinElmer, Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Biochips Market by Type
    • 5.1.1. DNA Chips
    • 5.1.2. Lab-on-a-Chip
    • 5.1.3. Protein Chips
    • 5.1.4. Others
  • 5.2. Global Biochips Market by Fabrication Technology
    • 5.2.1. Microarrays
    • 5.2.2. Microfluidics
  • 5.3. Global Biochips Market by End User
    • 5.3.1. Hospitalsand Diagnostic Centers
    • 5.3.2. Academic and Research Institutes
    • 5.3.3. Biotechnology and Pharmaceutical Companies

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. BioFluidix GmbH
  • 7.3. Cellix Ltd.
  • 7.4. Dynamic Biosensors GmbH
  • 7.5. Epigem Ltd.
  • 7.6. Fluidigm Corp.
  • 7.7. Horiba, Ltd.
  • 7.8. LifeSensors Inc.
  • 7.9. Luminex Corp.
  • 7.10. Menarini Silicon BiosystemsS.p.a.
  • 7.11. OriGene Technologies, Inc.
  • 7.12. Oxford Gene Technology IP Ltd.
  • 7.13. Randox Laboratories Ltd.
  • 7.14. Sengenics
  • 7.15. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSISBY TYPE, 2020-2027($ MILLION)
  • 2. GLOBAL DNA CHIPS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 3. GLOBAL LAB-ON-A-CHIP MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 4. GLOBAL PROTEIN CHIPS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 5. GLOBAL OTHER TYPES OF BIOCHIPS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 6. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS BY FABRICATION TECHNOLOGY, 2020-2027($ MILLION)
  • 7. GLOBAL MICROARRAYS BIOCHIPS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 8. GLOBAL MICROFLUIDICS BIOCHIPS MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 9. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY END-USER, 2020-2027($ MILLION)
  • 10. GLOBAL BIOCHIPSIN HOSPITALS AND DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 11. GLOBAL BIOCHIPSIN ACADEMIC AND RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS, 2020-2027($ MILLION)
  • 12. GLOBAL BIOCHIPSIN BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIESMARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 13. GLOBAL BIOCHIPS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027, ($ MILLION)

14. NORTH AMERICA BIOCHIPS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($MILLION)

15. NORTH AMERICA BIOCHIPS MARKET RESEARCH AND ANALYSISBY TYPE,2020-2027($MILLION)

16. NORTH AMERICA BIOCHIPS MARKET RESEARCH AND ANALYSIS BY FABRICATION TECHNOLOGY, 2020-2027($MILLION)

17. NORTH AMERICA BIOCHIPS MARKET RESEARCH AND ANALYSISBY END-USER,2020-2027($MILLION)

  • 18. EUROPE BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY COUNTRY, 2020-2027 ($ MILLION)
  • 19. EUROPE BIOCHIPS MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 20. EUROPE BIOCHIPS MARKET RESEARCH AND ANALYSISBY FABRICATION TECHNOLOGY, 2020-2027 ($ MILLION)
  • 21. EUROPE BIOCHIPS MARKET RESEARCH AND ANALYSISBY END-USER,2020-2027 ($ MILLION)
  • 22. APAC BIOCHIPS MARKET RESEARCH AND ANALYSIS BY TYPE,2020-2027 ($ MILLION)
  • 23. APAC BIOCHIPS MARKET RESEARCH AND ANALYSIS, BY FABRICATION TECHNOLOGY, 2020-2027 ($ MILLION)
  • 24. APAC BIOCHIPS MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 25. APAC BIOCHIPS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BIOCHIPS MARKET SHARE BY TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL BIOCHIPS MARKET SHARE BY FABRICATION TECHNOLOGY, 2020 VS 2027 (%)
  • 3. GLOBAL BIOCHIPS MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 4. GLOBAL BIOCHIPS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. NORTH AMERICAN BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 6. UNITED STATES BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 7. CANADA BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 8. EUROPEAN BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 9. UK BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 10. GERMANY BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 11. SPAIN BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. FRANCE BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. ITALY BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. ROE BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. ASIA PACIFIC BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. INDIA BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. CHINA BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. JAPAN BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. ROAPAC BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD BIOCHIPS MARKET SIZE, 2020-2027 ($ MILLION)